The relation between ZIKV infection during pregnancy and microcephaly in neonate has been established by the Brazillian Ministry of Health. Therefore, more attention regarding control of Aedes mosquito is required. Since it transmits this disease, which has more disastrous consequences than dengue viral infection. Potentially effective methods of prevention that are focused on reducing infections among pregnant women include avoiding unnecessary travel to areas of ongoing Zika virus transmission, avoiding unprotected sexual contact with partners who are at risk for Zika virus infection. According to Institute of Epidemiology Disease Control and Reseaech (IEDCR) there is nothing to panic at this moment for Bangladesh, but they stressed on mosquito control, which is the only tool to prevent and fight off Zika virus. They however, could not mention how the virus came to Bangladesh. May be somebody brought it while travelling. There is good survillence and testing system to detect the disease in Bangladesh.
Introduction
The Zika virus was first isolated from a Rhesus monkey in Zika forest of Uganda in April 1947 1 . 9 . This review describes the current understanding of the epidemiology, transmission, clinical characteristics, diagnosis and prevention of Zika virus.
Virology
The ZIKV is a mosquito-borne flavivirus and is thus related to dengue, yellow fever, Japanese encephalitis, and West Nile viruses. Like other flaviviruses, Zika virus is enveloped and icosahedral and has a nonsegmented, singlestranded, positive-sense RNA genome [10] [11] [12] . There are two lineages of Zika which are the African lineage and the Asian lineage 13 .
3.0. 
Vertical transmission:
The Zika virus can spread from an infected mother to her fetus during pregnancy or at the time of delivery 22 . Transmission through breast milk has not been documented, although the breast milk of a woman contained infective Zika viral particles in high titer who became symptomatic with Zika virus infection on the day of delivery 23 . 5.4. Through blood transfusion: As of April 2016, two cases of Zika transmission through blood transfusions have been reported from Brazil and French Polynesia 24 . 6.0. Pathogenesis Zika replicates in the mosquito's midgut epithelial cells and then in salivary gland cells. After 5-10 days, ZIKV can be found in the mosquito's saliva, which can then infect humans. If the mosquito's saiva is inoculated into humal skin, the virus can infect epidermal keratinocytes, skin fibroblasts in the skin and Langerhans cells 10 31 . The major advantage of a serology test is that it remains positive for several months or longer after infection. The major limitations are that it is slow to perform and prone to cross-react with other viruses related to Zika virus. A positive result may, in fact, represent a previous exposure to another virus or past vaccination (e.g. to Yellow fever). This makes the result difficult to interpret. Reliable testing regimens for the diagnosis of prenatal and antenatal Zika virus infection have not been established. Amniotic fluid has tested positive by RT-PCR in instance of congenital Zika virus infection. However, the sensitivity of RT-PCR in this context is unknown 35, 36 . At the time of delivery, cord blood can be tested by RT-PCR and MAC-ELISA, but the sensitivities of these tests for detecting prenatal Zika virus infection are unknown.
RT-PCR and immunohistochemical testing have been useful in establishing Zika virus infection in tissues of fetal losses and full-term infants who died shortly after birth 36 .
Treatment
Treatment for uncomplicated Zika virus infection focuses on symptoms. As with the other mosquito-borne flaviviruses, Zika virus disease is usually mild and requires no specific treatment. People sick with Zika virus should get plenty of rest, drink enough fluids, and treat pain and fever with common medicines. If symptoms worsen, they should seek medical care and advice 28 .
Prevention
As no vaccine exists against Zika virus, following prevention and control measures can be taken 32 like avoiding mosquito bites, reducing sexual transmission and controlling the mosquito vector. Potentially effective methods of prevention that are focused on reducing infections among pregnant women include i) avoiding unnecessary travel to areas of ongoing Zika virus transmission, ii) avoiding unprotected sexual contact with partners who are at risk for Zika virus infection, iii) and using mosquito repellent treatment for clothing, bed nets, window screens and air conditioning. To reduce the risk of sexual transmission and potential pregnancy complications related to Zika virus infection, the sexual partners of pregnant women, living or returning from areas where local transmission of Zika virus occurs should practice safer sex (including using condoms) or abstain from sex at least 8 weeks after their return, even if they don't have symptoms. If men experience Zika virus symptoms they should adopt safer sexual practices or consider abstinence for at least 6 months.
Vaccine development
The NIH Vaccine Research Center (U.S) began work towards developing a vaccine for Zika virus per January 2016 report 37 . In early February 2016, Bharat Biotech International (India) reported, that it was working on vaccines for Zika. They are using two approaches: 1) -recombinant‖, involving genetic engineering and 2) -inactivated‖, where the virus is incapable of reproducing itself but can still trigger an immune response 38, 39 . As of March 2016, 18 companies and institutions were developing vaccines against Zika, but none had yet reached clinical trials 40 .
Public Health Emergency
Public health emergency committee of WHO declares Zika virus is a global public health emergency 9 . As many as 1.3 million persons have been affected in Brazil alone and 55 countries or territories have been reported local transmission of the virus during 2016. Because of the ease of air travel and international trade, further spread into regions where the virus is not endemic is likely, and transmission is probable in locations with competent mosquito vectors. In January 2016, the United States Centers for Disease Control and Prevention (CDC) issued travel guidance on affected countries, including the use of enhanced precautions, and guidelines for pregnant women including considering postponing travel 41 . A robust, multifaceted response is underway that involves public health authorities, government agencies, the biomedical industry, medical practitioners, and researchers. Preventive measures specially vector control are a current priority. The relation between ZIKV infection during pregnancy and microcephaly in neonates is established. Pregnant woman should be concerned about exposure to endemic areas, and if possible, avoid remaining in such locations. The MOH of Brazil endorses instructing fertile women, who wish to have a child, about current situation of microcephaly 42 . A group of Scientist working with lab-grown cells may have found a clue to how the Zika virus could cause abnormally small heads in the children of woman who contract virus early in pregnancy. During early pregnancy, stem cells divide rapidly and travel to various areas, building the architecture of a healthy brain. The researcher hypothesis is that the virus invades some of these cells, killing some and preventing others from dividing. This impairs the construction of the cortex. This disruption in the building plan leaves the brain malformed and under developed. An underdeveloped brain leads to a smaller than normal head 43 . It is important for healthcare professionals to inform the population in general about the disease. Moreover, it is particularly important to make an early diagnosis of microcephaly and recognize possible brain dysfunctions to guide the patient to a health care unit that can implement early brain stimulation measures. It is known that the brain of microcephalic patients is proportionally smaller, thus about 90% of the cases are associated with some degree of intellectual disability 31 . Therefore any suspected case of microcephaly caused by ZIKV should be immediately notified to health authorities.
Travelers and Zika Virus treat
Travelers with active symptoms persist less than 10 days, before seeking medical attention, the best test is Zika virus PCR, although serology may also be performed on the precise timing of symptoms. Pregnant travellers with history of active symptoms compatible with Zika virus that started more than 10 days ago, the Zika virus PCR will likely to be negative. Serology for Zika virus would be the most appropriate test with this condition. At this time, based on our existing knowledge, pregnant women who developed active symptoms of Zika virus are expected to be most at risk for impact on their fetus. As a result, test should be offered and consideration to be given to consult with an infectious diseases specialist or maternal-fetal medicine specialist. For all asymptomatic travellers, routine testing is not recommended because interpreting the meaning of a negative Zika virus test is difficult. For example, depending on the timing of the test, antibodies may not yet have developed in the traveller, making the test result false negative. The use of barrier methods (such as condoms) for 6 months to prevent potential Zika virus transmission following return from travel is currently the safest approach. For pregnant travellers with a history of travel to an area at risk for Zika virus but with no history of symptoms, this scenario is the most difficult to navigate in terms of testing. It is estimated that approximately 75-80% of individual who are infected by the Zika virus never develop symptoms. However, the degree of risk to the fetus following asymptomatic infection in the pregnancy is still unknown 34 . As of April 2016, two cases of Zika transmission through blood transfusions have been reported from Brazil and French Polynesia 24 . A potential risk had been suspected based on a blood donor screening study during the French Polynesia Zika outbreak, in which 2.8% of donors from November 2013 and February 2014 tested positive for Zika RNA and were all asymptomatic at the time of blood donation 44 . Blood safety authorities need to be vigilant and should consider deferral of blood donors returning from areas with an outbreak of Zika virus. In areas endemic for Ades species, a preparedness plan to respond to future outbreaks of Zika virus infection should include emergency plans to sustain blood supply. The most effective plan to combat this outbreak of microcephaly is prevention. The most effective A. aegypti mosquito vector control relies on an integrated approach that involves elimination of mosquito breeding sites, application of larvicides and application of insecticide to kill adult mosquitoes. However, each of these approaches has substantial limitations. Communities are mobilized to reduce A. aegypti breeding sites.
Conclusion
The underlying reasons for the emergence of Zika virus in the past decade are unknown. Recent global increases in the incidence and spread of dengue, chikungunya and now Zika virus-all with A. aegypti as the primary vector-suggest common underlying mechanisms for their emergence, such as globalization and urbanization. Other possible explanations include viral mutations affecting transmission or virulence and viral introduction to previously unexposed populations leading to epidemic spread. Further research will be required to determine whether the recently observed associations with adverse birth outcomes and Guillian-Barre syndrome simply affect an increased incidence of infection or whether they result from a change in viral virulence.
